Fibrosing interstitial lung disease - Treatment with a cytotoxic agent Factor
Last reviewed for CCPS 16 December 2009.
Preliminary questions [40669]
40688 [1] there is some evidence that treatment with a cytotoxic agent may be a factor in the development or worsening of the condition under consideration.
40962 [1] the veteran has been treated with a cytotoxic agent at some time.
40963 [2] the veteran was treated with a cytotoxic agent for a malignant disease or in association with haematopoietic stem cell transplantation. 40964 — the treatment with a cytotoxic agent was for treatment of an illness or injury which is identifiable. 40967 — the veteran has established the causal connection between treatment with a cytotoxic agent and VEA service for fibrosing interstitial lung disease. 40968 — the veteran has established the causal connection between treatment with a cytotoxic agent and VEA service for the clinical onset of fibrosing interstitial lung disease. 40970 — the veteran has established the causal connection between treatment with a cytotoxic agent and operational service for the clinical onset of fibrosing interstitial lung disease. or 40971 — the veteran has established the causal connection between treatment with a cytotoxic agent and eligible service for the clinical onset of fibrosing interstitial lung disease. or 40969 — the veteran has established the causal connection between treatment with a cytotoxic agent and VEA service for the clinical worsening of fibrosing interstitial lung disease. 40972 — the veteran has established the causal connection between treatment with a cytotoxic agent and operational service for the clinical worsening of fibrosing interstitial lung disease. or 40973 — the veteran has established the causal connection between treatment with a cytotoxic agent and eligible service for the clinical worsening of fibrosing interstitial lung disease. Clinical onset and operational service [40970] 40974 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to operational service. [7] [8] Clinical onset and eligible service [40971] 40975 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to eligible service. [9] [8] Clinical worsening and operational service [40972] 40974 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to operational service. [10] [8] Clinical worsening and eligible service [40973] 40975 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to eligible service. [12] [8]
Links
[1] https://clik.dva.gov.au/ccpsh010rc-3
[2] clikpopup://CCPS/Treatment with cytotoxic agent for malignant disease or with haematopoietic stem cell transplantation
[3] clikpopup://CCPS/reject40963No
[4] clikpopup://CCPS/reject40965No
[5] clikpopup://CCPS/Reject/OnsetAfterService
[6] clikpopup://CCPS/Reject/NoPermanentWorsening
[7] clikpopup://CCPS/reject40966No
[8] clikpopup://CCPS/reject40974,40975No
[9] clikpopup://CCPS/reject40975No
[10] clikpopup://CCPS/reject40974No
[11] clikpopup://CCPS/Onset of FILD before Op service to which illness, for which had cytotoxic agent, is causally related
[12] clikpopup://CCPS/reject40976No
[13] clikpopup://CCPS/Onset of FILD before El service to which illness, for which had cytotoxic agent, is causally related
[14] clikpopup://CCPS/reject40977No